Outcome of vitreous surgery and intravitreal triamcinolone in various types of diabetic macular edema Taiga Kinoshita 1 , Takatoshi Maeno 1 , Takashi Nakai 1 , Masanori Fukumoto 1 , Takasumi Shimamoto 1 , Ryotaro Tano 1 , Minoru Yoshida 1 , Shinichi Sugita 1 , Masako Imoto 1 , Hirohisa Kawamura 1 , Hisashi Takenaka 1 , Toshiya Sakurai 1 , Ryuhei Kodaka 1 , Tomiya Mano 1 1Tane Memorial Eye Hosp pp.913-917
Published Date 2004/6/15
DOI https://doi.org/10.11477/mf.1410100593
  • Abstract
  • Look Inside

 Purpose:To evaluate the effect of vitreous surgery with adjunct use of intravitreal triamcinolone for diabetic macular edema. Cases and Methods:A total of 20 eyes in 13 cases received vitreous surgery for diabetic macular edema. Towards the end of surgery 4mg triamcinolone was injected into the vitreous. Cases were followed up for 6 to 9months after surgery. Findings:LogMar visual acuity improved by 2 lines or more in 13 eyes. It remained unchanged in 7 eyes. These 7 eyes had cystoid macular edema(CME)and circinate retinopathy prior to surgery. Post-op visual acuity was negatively correlated with the height of CME interspace. Conclusion:Adjunct use of intravitreal triamcinolone is effective for diabetic macular edema. It is of limited value in the presence of manifest CME or circinate retinopathy.

Copyright © 2004, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院